Apollo Hospitals Shares Soar: Citi Predicts 33% Rally on Strong Q3 & Attractive Valuations

• Apollo Hospitals shares surged over 5% after strong December quarter results.
• Citi reiterated a 'Buy' rating with a ₹9,600 price target, citing attractive valuations and robust operational performance.
• Consolidated Q3 revenue rose 17% to ₹6,500 crore, with EBITDA up 27% to ₹970 crore.
• Net profit jumped 35% to ₹502.3 crore, surpassing analyst estimates.
• Growth was driven by the hospitals business and improved margins in Apollo HealthCo, with Apollo 24/7 costs reduced.